Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2008
11/20/2008US20080287424 e.g. N-[amino(imino)methyl]-2-[2-(4-phenoxyphenyl)-5-phenyl-1H-pyrrol-1-yl]acetamide; beta -amyloid deposits and neurofibrillary tangles; cognition activator, neurodegenerative diseases; Alzheimer's disease, Down's syndrome
11/20/2008US20080286219 Hydroquinone derivative skin brightening compounds
11/19/2008EP1992614A1 3-(2-Alkoxy-phenyl)-substituted tetramates
11/19/2008EP1992613A1 Process for production of 3,4-disubstituted pyrrolidine derivative and intermediate for the production
11/19/2008EP1991233A2 Hydroxypiperidine derivatives and uses thereof
11/19/2008EP1603875A4 New process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate
11/19/2008EP1137798B1 A method of isolating stem cells
11/19/2008CN101309900A Substituted cycloalkene derivative
11/19/2008CN101307018A Diethylene triaminepentaacetic acid carboxyl active ester or analogues, method for synthesizing same and use
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN100434420C Compound inhibiting dipeptidyl peptidase iv
11/18/2008US7452999 Chemical process for the preparation of intermediates to obtain N-formyl hydroxy-lamine compounds
11/18/2008US7452908 Amide derivatives
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/18/2008CA2331850C Method of preparing carboxylic acid derivatives and condensing agent comprising a quaternary ammonium salt
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/13/2008WO2008137087A1 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
11/13/2008WO2008136527A1 Method for purification of optically active dioxopyrrolidine derivative
11/13/2008WO2008136428A1 Nitrogen-containing five-membered heterocyclic compound
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008135041A1 Adamantyloxyamine derivatives and related compounds for use as nmda and/or dpp-4 modulators for the therapy of cns diseases and diabetes
11/13/2008WO2008134923A1 A preparation method of thiol derivative as side chain intermediate for synthesis of carbapenem derivative
11/13/2008WO2008109681A3 Methods and intermediates for synthesis of selective dpp-iv inhibitors
11/13/2008WO2008097819A3 Chemical compounds
11/13/2008WO2008048714A3 Biradical polarizing agents for dynamic nuclear polarization
11/13/2008US20080281095 Asparatyl protease inhibitor
11/13/2008US20080280971 deuterated (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid, used for the treatment of dyslipidemia and/or hyperlipemia
11/13/2008US20080280970 Deuterium-enriched atorvastatin
11/13/2008US20080280969 (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide; neuropathic or inflammatory pain; modulation of use-dependent voltage-gated sodium channels
11/13/2008US20080280856 Fibroblast Activation Protein Inhibitor Compounds and Methods
11/13/2008US20080280334 Method for Preparing 3-Hydroxy-4-Hydroxymethyl-Pyrrolidine Compounds
11/13/2008US20080279932 Vildagliptin salt; in mixture with therapeutic agents such as antidiabetic agents; antilipemic agents; obesity; appetite control; hypotensive agents; cholesterol absorption moderators; anticoagulants; estrogen receptor moderators; transferring across blood-brain barrier
11/13/2008DE102007022007A1 Neuartike Pharmazeutika, Verfahren zu ihrer Herstellung und ihre Verwendung in der Prophylaxe und Therapie von ZNS-Erkrankungen und Diabetes Neuartike pharmaceuticals, to processes for their preparation and their use in the prophylaxis and treatment of CNS disorders and diabetes
11/13/2008CA2686033A1 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
11/12/2008EP1989180A1 Modified amino acids
11/12/2008EP1989162A1 Cycloalkylphenyl substituted cyclic ketoenols
11/12/2008EP1732918B1 Novel pyrrolidine-3,4-dicarboxamide derivatives
11/12/2008EP1727808B1 Biaryl amino acids and their use in dna binding oligomers
11/12/2008EP1305284B1 Process and intermediate compounds for the preparation of pyrrolidines
11/12/2008CN101305016A Metal complex, light-emitting material and light-emitting device
11/12/2008CN101304968A Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
11/12/2008CN101304967A Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
11/12/2008CN101304743A Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
11/12/2008CN101302181A Synthesis and application of four-chelate diamine pyrrole ligand compound
11/12/2008CN101302180A 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
11/12/2008CN100432071C Substituted 1H-indole-2-ketone compound and its preparation method and uses
11/11/2008US7449587 useful for solid phase chemical synthesis
11/11/2008US7449547 Process for the synthesis of distamycin and derivatives thereof using 1-methyl-4-formylamino-2-pyrrolecarbonyl chloride iteratively as an intermediate
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449315 Bifunctional energy-reversible acyl-compositions
11/06/2008WO2008131946A2 Substituted amide derivatives
11/06/2008WO2008109740A3 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
11/06/2008WO2008079266A3 Synthesis of pyrrolidine compounds
11/06/2008US20080275253 Lewis acid catalyzed halogenation of activated carbon atoms
11/06/2008US20080275247 Sulphur-containing metathesis catalysts
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275103 Reacting pyrrolylalkylcarbinole, furanylalkylcarbinole or thiophenylalkylcarbinole units; cyclodehydration, hydroboration, oxidation, palladium-catalyzed Suzuki-Miyaura cross-coupling; anticarcinogenic agents, antitumor, and antiproliferative agents; autoimmune and neurodegenerative diseases
11/06/2008US20080275087 Biphenylcarboxamides useful as lipid lowering agents
11/06/2008US20080275086 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes
11/06/2008US20080275053 Heterocyclyl Compounds
11/06/2008US20080275047 Tetrahydro-naphthalene derivatives
11/06/2008US20080275043 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1
11/06/2008US20080275028 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
11/06/2008US20080275021 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
11/06/2008US20080275003 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
11/06/2008US20080274082 Oximyl hydroxyamic analogs as hepatitis c virus protease inhibitor
11/06/2008DE102007020694A1 Schwefelhaltige Metathesekatalysatoren Sulfur-containing metathesis catalysts
11/06/2008DE102007020493A1 Substituierte Amid-Derivate Substituted amide derivatives
11/06/2008CA2685503A1 Substituted amide derivatives
11/05/2008EP1988075A1 Pyrrole derivative or salt thereof
11/05/2008EP1986997A2 New crystalline form of atorvastatin hemi-calcium
11/05/2008EP1986996A2 A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest
11/05/2008EP1768665B1 Peptidomimetic inhibitors of hiv protease
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008EP1319000B1 Use of 1-azabicyclo 2.2.2 octan-3-one derivatives for treating cancer tumors
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008CN101300229A 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
11/05/2008CN101300228A Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative
11/05/2008CN101300224A Process for making (s)-pregabalin
11/05/2008CN101300220A Hydrogen-catalysed process for preparing (meth)acrylates of n-hydroxyalkylated lactams
11/05/2008CN101298432A Preparation of L-pyrrolidone sodium carboxylate
11/05/2008CN101298431A Synthetic method of (2S, 3S)-2-[(carbamoyloxy) methyl]-3-amido-4-oxoazetidinone-1-sulfonate
11/05/2008CN100430405C Processes for preparing calcium salt forms of statins
11/05/2008CN100430404C Spiro oxazone derivative containing naphthalimide unit
11/05/2008CN100430386C Phenylalanine derivatives as depeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/05/2008CN100430377C N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
11/05/2008CN100430369C Hydroxy aromatic mannich base condensation products and use thereof as soot dispersants in lubricating oil compsns.
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/04/2008US7446210 Factor Xa compounds
11/04/2008US7446129 Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, then react resulting nucleophilic PDE4 inhibitor with benzylating agent, e.g., benzyl bromide; no emetogenic side effects
11/04/2008US7446125 Derivatives of nitroproline compounds, processes of manufacture and uses in the treatment of integrin mediated disorders
11/04/2008US7446115 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008CA2256328C Novel n-acylsulphonamides, novel mixtures of herbicides and antidotes and their use
10/2008
10/30/2008WO2008131368A2 Styrenyl derivative compounds for treating ophthalmic diseases and disorders
10/30/2008WO2008130332A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
10/30/2008WO2008130214A1 Oxazolidines derived from polyalkyl or polyalkylene n-hydroxyalkyl succinimides, method for preparation and use
1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 404